gammaCore
gammaCore is a medical device with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 71.4%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
71.4%
5 of 7 finished
28.6%
2 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhage
Vagal Nerve Stimulation for Treatment Resistant Major Depression
Safety and Efficacy of Non-invasive Vagus Nerve Stimulation in the Treatment of Headache in Subarachnoid Hemorrhage
Non-invasive Neurostimulation of the Vagus Nerve for the Treatment of Cluster Headache
Neurostimulation to the Vagus Nerve for the Reduction in Frequency of Seizures Associated With Epilepsy
Clinical Trials (8)
Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhage
Vagal Nerve Stimulation for Treatment Resistant Major Depression
Safety and Efficacy of Non-invasive Vagus Nerve Stimulation in the Treatment of Headache in Subarachnoid Hemorrhage
Non-invasive Neurostimulation of the Vagus Nerve for the Treatment of Cluster Headache
Neurostimulation to the Vagus Nerve for the Reduction in Frequency of Seizures Associated With Epilepsy
A Randomized Multicentre Study for the Acute Relief of Episodic and Chronic Cluster Headache.
Non-invasive Neurostimulation for the Relief of Migraine
Prevention and Acute Treatment of Chronic Cluster Headache Compared to Standard of Care
All 8 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 8